Our day-to-day at Memorias del IICS

A glimpse into our day-to-day at the Memorias del IICS office

Leer más

About

Memorias del Instituto de Investigaciones en Ciencias de la Salud (Mem. Inst. Investig. Cienc. Salud) is the official publication of the Institute of Research in Health Sciences (IICS) of the National University of Asunción (UNA), Paraguay. It publishes original scientific contributions in clinical medicine, biomedical research, microbiology, molecular biology, dentistry, nursing, nutrition, public health, health biotechnology, genetics, biochemistry, and related disciplines. Founded in 1983, the journal adopted its current name in 2002 and has been published exclusively online since 2015, incorporating XML article dissemination as of 2024. Since 2023, it operates under a continuous publication model. The journal accepts manuscripts in Spanish and English as original research articles, reviews, case studies, and brief communications. All content is available in open access, free of charge for authors and readers, under the Creative Commons Attribution 4.0 International License, in accordance with the Budapest Open Access Initiative (BOAI). It is indexed in BVS, SciELO Paraguay, HINARI, LILACS, DOAJ, Latindex, MIAR, Dialnet, CiteFactor, Google Scholar, LivRe, BASE, EBSCO, and Web of Science – SciELO Citation Index. The journal is funded by IICS-UNA, supports the OAI-PMH protocol for metadata harvesting, and uses the LOCKSS system for digital preservation of its contents.

 
Leer más

Peer Review Process

Manuscripts submitted to Memorias del Instituto de Investigaciones en Ciencias de la Salud undergo a double-blind peer review process, in which the identities of both authors and reviewers remain anonymous throughout the evaluation. Each manuscript is assessed by a minimum of two external reviewers with expertise in the relevant subject area, who are given a period of 30 days to submit their evaluation. Reviewers assess the originality, methodological rigor, scientific relevance, and clarity of presentation of each work. Based on the reviewers' reports, the Editorial Committee decides whether to accept, request revisions, or reject the manuscript, and communicates the decision to the authors as promptly as possible. This process ensures impartiality, transparency, and the scientific quality of published articles.

Leer más

Call for Papers

The Institute of Research in Health Sciences (IICS) of the National University of Asunción (UNA) invites researchers, academics, and health professionals to submit their manuscripts for consideration in the 2026 Volume of Memorias del Instituto de Investigaciones en Ciencias de la Salud (Mem. Inst. Investig. Cienc. Salud). The journal accepts original and unpublished contributions in Spanish as original research articles, review articles, case studies, and brief communications, in the areas of clinical medicine, biomedical research, microbiology, molecular biology, dentistry, nursing, nutrition, public health, health biotechnology, genetics, biochemistry, and related disciplines. The call for submissions is open and ongoing, and manuscripts may be submitted at any time of the year through the journal's online submission system. All received manuscripts undergo double-blind peer review. The journal is open access, with no charges for authors or readers. For further information on submission guidelines, please refer to the author instructions available on the journal's website.

Leer más

Conocimiento del consumo de ácido fólico y su relación con los defectos del tubo neural en mujeres puérperas

Authors

  • Miguel Ruoti Cosp
  • Monica Ruoti Author
  • Graciela Rojas de Torres Author
  • Mónica Ontano Author
  • Stella Rodríguez Author

Keywords:

ácido fólico, conocimiento, Paraguay, defectos del tubo neural, planificación del embarazo.

Abstract

Los defectos del tubo neural (DTN) incluyen un amplio espectro de malformaciones congénitas. La más frecuente es la espina bífida abierta que cursa con grados variables de parálisis de las extremidades inferiores y alteraciones vesicales e intestinales. Actualmente se pueden reducir los DTN mediante el ácido fólico (AF). El objetivo principal de este estudio fue determinar el conocimiento periconcepcional de AF. Se realizó un cuestionario a 800 mujeres puérperas, internadas en la Cátedra de Ginecología y Obstetricia - Facultad de Ciencias Médicas, Cruz Roja Paraguaya y Hospital San Pablo (ambos MSP y BS), desde el 1 de febrero al 31 de noviembre de 2003. La mayoría tenía entre 20 y 24 años (29,8%); cursaron el bachillerato 54,3%. El embarazo fue planificado en 21,8%. A la pregunta ―ha oído hablar del AF‖ 66 (8,2%) de las 800 puérperas respondieron afirmativamente. De éstas, 50 (75,6% de este subgrupo) sabían que es una vitamina, 39 (59,1%) que el AF es útil para prevenir los DTN y 26 (39,4%) que se debe consumir desde antes de comenzar el embarazo. Este estudio mostró bajo nivel de conocimientos de las puérperas sobre lo que es y los beneficios del AF en la prevención primaria de los DTN, lo que evidencia la importancia de insistir en programas de información y educación sanitaria, a toda mujer en edad fértil aunque no planee su embarazo, sobre esta medida de prevención primaria de los DTN.

Downloads

Download data is not yet available.

References

Herbert V. Folic acid. In: Shils ME, Ilson JA, Shike M, Ross AC (eds). Modern nutrition in health and diseases. 9th ed. Baltimore: Williams & Wilkins. 1999. p.433-46.

Kelly GS. Folates: supplemental forms and therapeutic applications. Alter Med Rev 1998; 3:208-20.

O’Rahilly R, Müller F (eds). Embriología y teratología humanas. Colección de Medicina Materno-Fetal. Barcelona: Masson. 1998.

Sánchez S, Ruoti Cosp M, Airaldi L, Calabrese E, Centurión S, Ruiz O et al. Prenatal diagnosis of central nervous system malformations. En: XI International Congress of the Society The Fetus as a Patient 2005: Controversies in Perinatal Medicine; 2005 april 27-30; Buenos Aires: Society The Fetus as a Patient; 2005. CD de Resúmenes de Comunicaciones Libres y Pósters.

De-Regil LM, Fernández-Gaxiola AC, Dowswell T, Peña-Rosas JP. Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane Database Syst Rev. 2010; 6(10):CD007950.

Wolff T, Witkop CT, Miller T, Syed SB; U.S. Preventive Services Task Force. Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2009 May 5; 150(9):632-9.

Goh YI, Koren G. Folic acid in pregnancy and fetal outcomes. J Obstet Gynaecol. 2008; 28:(1): 3-13.

Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA. 1993; 269(10):1257-61.

Shaw GM, Schaffer D, Velie EM, Morland K, Harris JA. Periconceptional vitamin use,

dietary folate, and the ocurrence of neural tube defects. Epidemiology. 1995; 6(3):219-26.

Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, Scott JM. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med. 1993; 86(11):703-8.

van der Put NM, Thomas CM, Eskes TK, Trijbels FJ, Steeghers-Theunissen RP, Mariman EC et al. Altered folate and vitamin B12 metabolism in families with spina bifida offspring. QJM. 1997; 90(8):505-10.

Bower C, Stanley FJ. Periconceptional vitamin supplementation and neural tube defects; evidence from a case-control study in Western Australia and a review of recent publications. J Epidemiol Community Health. 1992; 46(2):157-61.

Liu S, West R, Randell E, Longerich L, O'connor KS, Scott H et al. A comprehensive evaluation of food fortification with folic acid for the primary prevention of neural tube defects. BMC Pregnancy Childbirth. 2004; 4:20

Wilson RD, Johnson JA, Wyatt P, Allen V, Gagnon A, Langlois S et al. Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can. 2007; 29(12):1003-26. Erratum in: J Obstet Gynaecol Can. 2008;30(3):193.

Department of Health. Report from an Expert Advisory Group of folic acid and the prevention of neural tube defects. London: Department of Health; Scottish Office Home and Health Department; Welsh Office; Department Health and Social Services, Northern Ireland. 1992.

Folic acid for the prevention of recurrent neural tube defects. ACOG Committee Opinion: Committee on Obstetrics: maternal and fetal medicine number 120—March 1993. Int J Gynaecol Obstet. 1993; 42(1):75-7.

SOGC Genetics Committee. Recommendations on the use of folic acid for the prevention of neural tube defects. J Soc Obstet Gynaecol Can. 1993; 15(suppl):41-6.

American Academy of Pediatrics, Committee on Genetics. Folic acid for the prevention of neural tube defects. Pediatrics. 1999; 104(2 Pt 1):325-7.

Green NS. Folic acid supplementation and prevention of birth defect. J. Nutr. 2002; 132: (8 Suppl):2356S–60S.

Centro Paraguayo de Estudios de Población (CEPEP), United States Agengy for International Development (USAID), Centres for Disease Control and Prevention (CDC). Encuesta nacional de salud materno infantil 1998. Asunción: CEPEP; 1997.

Centro Paraguayo de Estudios de Población (CEPEP), United States Agency for International Development (USAID), Centers for Disease Control and Prevention (CDC). Encuesta nacional de demografía y salud 1990. Asunción: CEPEP; 1991.

Centro Paraguayo de Estudios de Población (CEPEP), United States Agency for International Development (USAID), Centers for Disease Control and Prevention (CDC). Encuesta nacional de demografía y salud reproductiva 1995-1996. Asunción: CEPEO; 1997.

Sánchez S, Ruoti Cosp, Calabrese E, Cueto R, Díaz C, Ascurra M. Diagnóstico prenatal de las malformaciones del sistema nervioso central. Ginecología y Obstetricia. 2005. CD de Resúmenes de Comunicaciones Libres y Pósters

Elkin A, Higham J. Folic acid supplements are more effective than increased dietary folate intake in elevating serum folate levels. BJOG. 2000;107(2):285-9.

Fabre González E, González de Agüero R, Ruoti Cosp M. Consulta preconcepcional En: Cabero Roura L, director. Tratado de ginecología, obstetricia y medicina de la reproducción (T.1). Madrid: Editorial Panamericana; 2003. p.278-92.

Brandenburg H, Traas MA, Laudy J, Ursem N, Westerveld AM, Wladimiroff JW. Periconceptional use of folic acid amongst women of advanced maternal age. Prenat Diagn. 1999;19(2):132-5.

Pardo R, Lay-Son G, Aranda W, Dib M, Espina P, Muñoz M et al. Conocimiento sobre el ácido fólico en la prevención de defectos de cierre del tubo neural: una encuesta a mujeres que viven en Santiago de Chile. Rev Méd Chile. 2007;135:1551-7.

Fabre González E, Lou Mercadé AC, González de Agüero Laborda R, Gallo Vallejo M, Sobreviela Laserrada M, Ruoti Cosp M. Prevención primaria de los defectos del tubo neural. Folia Clin Obstet Ginecol 2002; 32:8-41.

Botto LD, Lisi A, Robert-Gnansia E, Erickson JD, Vollset SE, Mastroiacovo P,. International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working? BMJ. 2005; 330 (7491):571.

Corral S E, Moreno S R, Pérez G G, Ojeda B ME, Valenzuela G H, Reascos M M, Sepúlveda L W. Defectos congénitos cráneo-encefálicos: variedades y respuesta a la fortificación de la harina con ácido fólico. Rev Med Chil. 2006;134(9):1129-34.

Centers for Disease Control and Prevention. Use of folic acid-containing supplements among women of childbearing age – United Stated, 1997. MMWR. 1998;47(7):131-134.

Oakely GP. Folic acid-preventable spina bifida and anencephaly. JAMA. 1993;269:1292-3.

Downloads

Published

2016-04-01

Issue

Vol. 14 No. 1 (2016): Enero-Abril

Section

Original Articles

How to Cite

Ruoti Cosp, M., Ruoti, M., Rojas de Torres, G., Ontano, M., & Rodríguez, S. (2016). Conocimiento del consumo de ácido fólico y su relación con los defectos del tubo neural en mujeres puérperas. Memorias Del Instituto De Investigaciones En Ciencias De La Salud, 14(1). https://revistascientificas.una.py/index.php/RIIC/article/view/1845